©2022 Stanford Medicine
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Trial ID: NCT00383500
To compare the effectiveness of usual treatments for lymphedema [massage and elastic compression sleeve, instituted at-risk and before the development of swelling (lymphedema)], compared to the use of a newly-marketed device, the Flexitouch, which electronically simulates the effect of massage upon lymph flow.
To Prospectively Evaluate the Potential for Simple, Effective Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
- Unilateral breast cancer
- Scheduled to undergo breast surgery and axillary lymph node dissection, with or
without breast conserving techniques.
- Referred to the surgeons of the Stanford University Breast Cancer Program
- Capacity to provide informed consent.
- All experimental protocols will be reviewed and approved by the Stanford Institutional
Review Board for the Protection of Human Subjects.
- Other serious systemic illness (renal failure, hepatic dysfunction, congestive heart
failure, neurological or psychological impairment) that would confound the study or
impair the patients' ability to participate.
- Recurrent breast cancer or other forms of pre-existing lymphedema.
device: Class 1 compression garment
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Les Roche, RN